Mesa Laboratories Reports 2026 Annual Meeting Voting Results

What Happened Mesa Laboratories, Inc. (MLAB) filed an 8-K on Sept. 8, 2026 reporting certified results from its Annual Meeting. Of 5,595,869 shares entitled to vote, 4,872,692 shares were represented. Seven directors were re-elected for one-year terms to the board, the appointment of Baker Tilly US, LLP as independent registered public accountants for fiscal 2027 was ratified, and the company’s named executive officer compensation was approved on a non-binding advisory basis.

Key Details

• Shares entitled to vote: 5,595,869; shares represented at meeting: 4,872,692.
• Director election vote totals (For / Withheld / Broker Non-Votes):
  • John Sullivan, Ph.D.: 4,388,976 / 145,521 / 338,195
  • Siddhartha Kadia, Ph.D.: 4,421,045 / 113,452 / 338,195
  • Shiraz Ladiwala: 4,402,912 / 131,585 / 338,195
  • Jenny Alltoft: 4,395,928 / 138,569 / 338,195
  • Mark Capone: 4,405,110 / 129,387 / 338,195
  • Shannon Hall: 4,399,078 / 135,419 / 338,195
  • R. Tony Tripeny: 4,352,734 / 181,763 / 338,195
• Auditor ratification (Proposal 2): Baker Tilly US, LLP approved — For: 4,814,383; Against: 56,778; Abstain: 1,531.
• Advisory vote on executive compensation (Proposal 3): Approved — For: 4,317,389; Against: 136,782; Abstain: 80,326; Broker Non-Votes: 338,195.

Why It Matters These results confirm board continuity with all nominees elected and formalize the auditor selection for the upcoming fiscal year, which affects financial reporting oversight. The non-binding approval of executive compensation indicates majority shareholder support for pay practices disclosed in the proxy; because it is advisory, the board can consider the vote when setting future compensation.